ATE216708T1 - Tc oder re radiomarkierte somastostatin analoge - Google Patents

Tc oder re radiomarkierte somastostatin analoge

Info

Publication number
ATE216708T1
ATE216708T1 AT95933284T AT95933284T ATE216708T1 AT E216708 T1 ATE216708 T1 AT E216708T1 AT 95933284 T AT95933284 T AT 95933284T AT 95933284 T AT95933284 T AT 95933284T AT E216708 T1 ATE216708 T1 AT E216708T1
Authority
AT
Austria
Prior art keywords
radiom
labeled
somastostatin analogue
useful
chelate
Prior art date
Application number
AT95933284T
Other languages
English (en)
Inventor
Richard J Flanagan
Jean-Marc Dufour
Keith T Hogan
Original Assignee
Merck Frosst Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Frosst Canada Inc filed Critical Merck Frosst Canada Inc
Application granted granted Critical
Publication of ATE216708T1 publication Critical patent/ATE216708T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Details Of Aerials (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT95933284T 1994-10-13 1995-10-11 Tc oder re radiomarkierte somastostatin analoge ATE216708T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/322,880 US5556939A (en) 1994-10-13 1994-10-13 TC or RE radionuclide labelled chelate, hexapeptide complexes useful for diagnostic or therapeutic applications
PCT/CA1995/000573 WO1996011954A1 (en) 1994-10-13 1995-10-11 Tc or re radiolabelled somatostatin analogs

Publications (1)

Publication Number Publication Date
ATE216708T1 true ATE216708T1 (de) 2002-05-15

Family

ID=23256849

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95933284T ATE216708T1 (de) 1994-10-13 1995-10-11 Tc oder re radiomarkierte somastostatin analoge

Country Status (7)

Country Link
US (1) US5556939A (de)
EP (1) EP0785951B1 (de)
JP (1) JP3630239B2 (de)
AT (1) ATE216708T1 (de)
AU (1) AU3602795A (de)
DE (1) DE69526515T2 (de)
WO (1) WO1996011954A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443815A (en) * 1991-11-27 1995-08-22 Diatech, Inc. Technetium-99m labeled peptides for imaging
US7238340B1 (en) * 1991-11-27 2007-07-03 Cis Bio International Monoamine, diamide, thiol-containing metal chelating agents
US5783170A (en) * 1991-11-27 1998-07-21 Diatide, Inc. Peptide-metal chelate conjugates
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
US5932189A (en) * 1994-07-29 1999-08-03 Diatech, Inc. Cyclic peptide somatostatin analogs
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
US5632969A (en) * 1994-10-13 1997-05-27 Merck & Co., Inc. N3 S2 chelating ligands optionally radiolabelled with Tc or Re, useful for diagnostic or therapeutic applications
EP0975374B1 (de) * 1996-07-12 2007-12-05 Immunomedics, Inc. Radiometall-bindende peptide analoge
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6537520B1 (en) 1998-03-31 2003-03-25 Bristol-Myers Squibb Pharma Company Pharmaceuticals for the imaging of angiogenic disorders
US6524553B2 (en) * 1998-03-31 2003-02-25 Bristol-Myers Squibb Pharma Company Quinolone vitronectin receptor antagonist pharmaceuticals
EP1140204A2 (de) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Vitronektin-rezeptor antagonist arzeimittheln
US6794518B1 (en) * 1998-12-18 2004-09-21 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
CA2349333A1 (en) 1998-12-18 2000-06-22 Du Pont Pharmaceuticals Company Vitronectin receptor antagonist pharmaceuticals
US6511649B1 (en) * 1998-12-18 2003-01-28 Thomas D. Harris Vitronectin receptor antagonist pharmaceuticals
US6989139B2 (en) * 2000-02-15 2006-01-24 Bristol-Myers Squibb Pharma Company Matrix metalloproteinase inhibitors
CN100352805C (zh) 2000-11-08 2007-12-05 鲁汶天主教大学研究开发部 用作造影剂的取代的联吲哚衍生物、包含它们的药物组合物以及制造它们的中间体
EP1337278A2 (de) 2000-11-27 2003-08-27 Bristol-Myers Squibb Medical Imaging, Inc. Gleichzeitiges imaging der kardialen perfusion und eines auf den vitronektin rezeptor zielgerichteten agens
US6623721B2 (en) 2000-12-18 2003-09-23 Draximage, Inc. Bifunctional chelating compounds containing hydroxamic acid residues
US6838074B2 (en) 2001-08-08 2005-01-04 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7138104B2 (en) * 2001-08-08 2006-11-21 Bristol-Myers Squibb Company Simultaneous imaging of cardiac perfusion and a vitronectin receptor targeted imaging agent
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US7211240B2 (en) 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
AU2003278807A1 (en) 2002-03-01 2004-08-13 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
ES2398393T3 (es) 2002-03-01 2013-03-15 Dyax Corp. Péptidos de unión a KDR y a VEGF/KDR y su uso en diagnóstico y terapia
ES2396368T3 (es) 2003-03-03 2013-02-21 Dyax Corporation Péptidos que se unen específicamente al receptor del HGF (CMET) y usos de los mismos
WO2006033714A2 (en) * 2004-08-10 2006-03-30 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Metal chelators and methods of their use
EP1717247A1 (de) * 2005-04-28 2006-11-02 Schering AG Zyklische Peptide, die sich am Somatostatinrezeptor binden
WO2006114324A1 (en) * 2005-04-28 2006-11-02 Schering Ag Compounds comprising cyclized somatostatin receptor binding peptides
US20210386877A1 (en) * 2019-01-10 2021-12-16 Andarix Pharmaceuticals, Inc. Radiotherapeutic combination therapy for the treatment of cancer

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3780015A (en) * 1971-12-30 1973-12-18 Merck & Co Inc Process for preparing lysine containing peptides
US4707352A (en) * 1984-01-30 1987-11-17 Enzo Biochem, Inc. Method of radioactively labeling diagnostic and therapeutic agents containing a chelating group
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
DE3522638A1 (de) * 1985-06-25 1987-01-08 Diamalt Ag Neue somatostatin-derivate
AU593611B2 (en) * 1986-02-14 1990-02-15 Nihon Medi-Physics Co., Ltd. High molecular compounds having amino groups, and their utilization
US4861869A (en) * 1986-05-29 1989-08-29 Mallinckrodt, Inc. Coupling agents for joining radionuclide metal ions with biologically useful proteins
NL194729C (nl) * 1986-10-13 2003-01-07 Novartis Ag Werkwijze voor de bereiding van peptidealcoholen via vaste fase.
CH679045A5 (de) * 1987-06-29 1991-12-13 Sandoz Ag
MY106120A (en) * 1988-12-05 1995-03-31 Novartis Ag Peptide derivatives.
US5101041A (en) * 1989-04-26 1992-03-31 The Curators Of The University Of Missouri Triamines and their derivatives as bifunctional chelating agents
US5382654A (en) * 1992-02-05 1995-01-17 Mallinckrodt Medical, Inc. Radiolabelled peptide compounds
US5225180A (en) * 1991-09-10 1993-07-06 Diatech, Inc. Technetium-99m labeled somatostatin-derived peptides for imaging
DK0720621T3 (da) * 1992-01-14 2001-08-06 Diatide Inc Radiomærkede somatostation-afledte peptider til billeddannende og terapeutiske anvendelser
US5716596A (en) * 1992-06-23 1998-02-10 Diatide, Inc. Radioactively labeled somatostatin-derived peptides for imaging and therapeutic uses
NO940080L (no) * 1993-01-12 1994-07-13 Sandoz Ag Polypeptider , fremgangsmåte for deres fremstilling og farmasöytiske preparater derav

Also Published As

Publication number Publication date
JP3630239B2 (ja) 2005-03-16
DE69526515D1 (de) 2002-05-29
US5556939A (en) 1996-09-17
JPH10507180A (ja) 1998-07-14
EP0785951A1 (de) 1997-07-30
EP0785951B1 (de) 2002-04-24
WO1996011954A1 (en) 1996-04-25
AU3602795A (en) 1996-05-06
DE69526515T2 (de) 2002-11-28

Similar Documents

Publication Publication Date Title
ATE216708T1 (de) Tc oder re radiomarkierte somastostatin analoge
ATE277906T1 (de) 4-carboxamino-2-methyl-1,2,3,4- tetrahydrochinoline als cetp inhibitoren
EA200401304A1 (ru) Набор для ингаляции с ингаляционным порошком, содержащим тиотропий
FI950821A0 (fi) Säteilyllä kovetettavissa olevia pigmenttipitoisia koostumuksia
SE8302693L (sv) Heterocykliska foreningar
DK1007520T3 (da) 2-aminopyridiner som indeholder sammensluttede ringsubstituenter som NOS inhibitorer
GB9806008D0 (en) Programming development environments performed by computers
FI954738A7 (fi) Tetrasykliini yhdisteet dopamiiniagonisteina
BR0210965A (pt) Conjugado de quelador, complexo de radiometal, radiofármaco, kit para a preparação do mesmo, composto, e, processo para a preparação do mesmo
WO2002032871A3 (en) Compounds and methods for treating multidrug resistance
DE69535638D1 (de) Peptid-chelator konjugate
DE69405729D1 (de) 1,4-benzoxazinderivate als kalium kanalaktivatoren
EA199900362A1 (ru) Новые соединения, полезные для использования в качестве нейрозащитных средств
ATE219490T1 (de) Indazoleamid-verbindungen als serotoninergene mittel
ATE296800T1 (de) Sulfonylamino-carbonsäure-n-arylamide als guanylatcyclase-aktivatoren
EA200000975A1 (ru) 6-(2-гало-4-алкоксифенил)триазолпиримидины с фунгицидным действием
DK0592440T3 (da) Technetium-99m-komplekser til anvendelse som radiofarmaceutiske midler
DE69720317D1 (de) Benzoxazole Derivate als Serotonin 5-HT3 Rezeptor partiell Aktivator
GB9816616D0 (en) Metalloproteinase inhibitors
AU3602695A (en) Novel n3s2 chelating ligands optionally radiolabelled with tc or re, useful for diagnostic or therapeutic applications
DE4393754T1 (de) Ladungskontrollmittel-Zusammensetzung und Toner, welcher diese enthält
WO2002032869A3 (en) Substituted heterocyclic compounds for treating multidrug resistance
ATE403655T1 (de) Imidazopyridinderivate als induzierbare no- synthaseinhibitoren
NO961769D0 (no) Avlukke for arbeid med giftig substans
ATE118763T1 (de) Phenolisches amin als antimelanoma- und depigmentierungsmittel.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties